Active substances

Valaciclovir›

J05AB11 Antiinfectives for systemic use | Direct acting antivirals | Nucleosides and nucleotides excl. reverse transcriptase inhibitors

Indicated for: herpes virus infections

Valdecoxib›

M01AH03 Musculo-skeletal system | Antiinflammatory and antirheumatic products | Antiinflammatory and antirheumatic products, non-steroids | Coxibs

Indicated for: pain and inflammation

Valerian›

N05CXN3 Nervous system | Hypnotics and sedatives | Hypnotics and sedatives in combination, excl. barbiturates

Indicated for: mild restlessness; minor sleep disorders

Valerian + lemon balm + mint›

N05CXN3 Nervous system | Hypnotics and sedatives | Hypnotics and sedatives in combination, excl. barbiturates

Indicated for: mild restlessness; minor sleep disorders

Valganciclovir›

J05AB14 Antiinfectives for systemic use | Direct acting antivirals | Nucleosides and nucleotides excl. reverse transcriptase inhibitors

Indicated for: cytomegalovirus infection

Valproic acid + salts›

N03AG01 Nervous system | Antiepileptics | Antiepileptics | Fatty acid derivatives

Indicated for: epilepsy; bipolar disorder

Valsartan›

C09CA03 Cardiovascular system | Angiotensin II receptor blockers (arbs), plain | Angiotensin ii receptor blockers (arbs), plain

Indicated for: hypertension

Valsartan + amlodipine›

C09DB01 Cardiovascular system | Angiotensin II receptor blockers (ARBs), combinations | Angiotensin ii receptor blockers (arbs) and calcium channel blockers

Indicated for: hypertension

Valsartan + hydrochlorothiazide›

C09DA03 Cardiovascular system | Angiotensin II receptor blockers (ARBs), combinations | Angiotensin ii receptor blockers (arbs) and diuretics

Indicated for: hypertension

Valsartan + indapamide›

C09DA03 Cardiovascular system | Angiotensin II receptor blockers (ARBs), combinations | Angiotensin ii receptor blockers (arbs) and diuretics

Indicated for: hypertension

Vamorolone›

H02AB18 Systemic hormonal preparations, excluding sex hormones and insulins | Corticosteroids for systemic use | Corticosteroids for systemic use, plain | Glucocorticoids

Indicated for: Duchenne muscular dystrophy

Vancomycin›

J01XA01 Antiinfectives for systemic use | Other antibacterials | Glycopeptide antibacterials

Indicated for: bacterial infections

Vandetanib›

L01EX04 Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Other protein kinase inhibitors

Indicated for: cancer

Vardenafil›

G04BE09 Genito urinary system and sex hormones | Urologicals | Urologicals | Drugs used in erectile dysfunction

Indicated for: erectile dysfunction

Varenicline›

N07BA03 Nervous system | Drugs used in addictive disorders | Drugs used in nicotine dependence

Indicated for: smoking cessation

Varicella-zoster vaccine (recombinant, adjuvanted)›

J07BK03 Antiinfectives for systemic use | Viral vaccines | Varicella zoster vaccines

Indicated for: prevention of herpes zoster

Vasopressin›

H01BA01 Systemic hormonal preparations, excluding sex hormones and insulins | Posterior pituitary lobe hormones | Vasopressin and analogues

Indicated for: vasodilatory shock; diabetes insipidus

Vasopressin (argipressin)›

H01BA01 Systemic hormonal preparations, excluding sex hormones and insulins | Posterior pituitary lobe hormones | Vasopressin and analogues

Indicated for: vasodilatory shock; diabetes insipidus

Vecuronium›

M03AC03 Musculo-skeletal system | Muscle relaxants | Muscle relaxants, peripherally acting agents | Other quaternary ammonium compounds

Indicated for: muscle relaxation in anesthesia

Vedolizumab›

L04AG05 Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Monoclonal antibodies

Indicated for: inflammatory bowel disease

Velaglucerase alfa›

A16AB10 Alimentary tract and metabolism | Other alimentary tract and metabolism products | Other alimentary tract and metabolism products | Enzymes

Indicated for: lysosomal enzyme deficiency

Velmanase alfa›

A16AB15 Alimentary tract and metabolism | Other alimentary tract and metabolism products | Other alimentary tract and metabolism products | Enzymes

Indicated for: lysosomal enzyme deficiency

Vemurafenib›

L01EC01 Antineoplastic and immunomodulating agents | Protein kinase inhibitors | B-raf serine-threonine kinase (BRAF) inhibitors

Indicated for: melanoma

Venetoclax›

L01XX52 Antineoplastic and immunomodulating agents | Other antineoplastic agents

Indicated for: hematologic malignancies

Venlafaxine›

N06AX16 Nervous system | Antidepressants | Other antidepressants

Indicated for: depression; anxiety disorders

Verapamil›

C08DA01 Cardiovascular system | Selective calcium channel blockers with direct cardiac effects | Phenylalkylamine derivatives

Indicated for: hypertension; angina; arrhythmias

Verapamil + trandolapril›

C09BB10 Cardiovascular system | Ace inhibitors, combinations | Ace inhibitors and calcium channel blockers

Indicated for: hypertension

Vernakalant›

C01BG11 Cardiovascular system | Antiarrhythmics, class I and III | Other antiarrhythmics, class I and III

Indicated for: cardiac arrhythmias

Verteporfin›

S01LA01 Sensory organs | Ocular vascular disorder agents | Antineovascularisation agents

Indicated for: macular degeneration; diabetic macular edema

Vestronidase alfa›

A16AB18 Alimentary tract and metabolism | Other alimentary tract and metabolism products | Other alimentary tract and metabolism products | Enzymes

Indicated for: lysosomal enzyme deficiency